Cargando…

Arterial hypertension in systemic sclerosis

INTRODUCTION: Arterial hypertension (AH) is common in systemic connective tissue diseases. AIM: To evaluate the incidence of AH in patients with systemic sclerosis (SSc) and to present clinical characteristics of the group diagnosed with AH. MATERIAL AND METHODS: The study involved 108 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wielosz, Ewa, Dryglewska, Magdalena, Górak, Anna, Łyś, Ewa, Majdan, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704450/ https://www.ncbi.nlm.nih.gov/pubmed/36457666 http://dx.doi.org/10.5114/ada.2022.120881

Ejemplares similares

Clinical consequences of the presence of anti-RNA Pol III antibodies in systemic sclerosis
por: Wielosz, Ewa, et al.
Publicado: (2021)

Overlap syndromes in systemic sclerosis
por: Wielosz, Ewa, et al.
Publicado: (2018)

Comparison of clinical and serological parameters in female and male patients with systemic sclerosis
por: Wielosz, Ewa, et al.
Publicado: (2016)

Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients – a 24-month observation
por: Wielosz, Ewa, et al.
Publicado: (2017)

Haematological abnormalities in systemic sclerosis
por: Wielosz, Ewa, et al.
Publicado: (2020)

Methods of assessment of joint involvement in various systemic connective tissue diseases
por: Kardas, Tobiasz, et al.
Publicado: (2022)

Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis – case report and literature review
por: Wielosz, Ewa, et al.
Publicado: (2017)

Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sjögren's syndrome patients
por: Koszarny, Arkadiusz, et al.
Publicado: (2015)

The usefulness of nailfold capillaroscopy in “scleroderma-spectrum” disorders
por: Wielosz, Ewa
Publicado: (2021)

Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations
por: Suszek, Dorota, et al.
Publicado: (2020)

Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2010)

Peptidyl Arginine Deiminase Type 4 Gene Promoter Hypo-Methylation in Rheumatoid Arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020)

The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA/RF negative rheumatoid arthritis patients
por: Kolarz, Bogdan, et al.
Publicado: (2021)

Antiphospholipid antibodies during 6-month treatment with infliximab: A preliminary report
por: Kolarz, Bogdan, et al.
Publicado: (2014)

Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2020)

Continuous laccase concentration in an aqueous two-phase system
por: Blatkiewicz, Michał, et al.
Publicado: (2017)

Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
por: Ratanawatkul, Pailin, et al.
Publicado: (2020)

Reductive activity of free and immobilized cells of cyanobacteria toward oxophosphonates—comparative study
por: Górak, Monika, et al.
Publicado: (2016)

Mesenchymal stem cells in systemic sclerosis therapy
por: Dudek, Daniel Witold, et al.
Publicado: (2020)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Ocular manifestations in patients with systemic sclerosis
por: Kozikowska, Małgorzata, et al.
Publicado: (2020)

Clinical pattern of systemic sclerosis in Central Ukraine. Association between clinical manifestations of systemic sclerosis and hypertension
por: Semenov, Viktor, et al.
Publicado: (2018)

Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
por: Almaaitah, Saja, et al.
Publicado: (2020)

The expression profiling of microRNA in systemic sclerosis-associated pulmonary arterial hypertension
por: Huang, Yu-Xia, et al.
Publicado: (2021)

Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
por: Sun, Qian, et al.
Publicado: (2020)

The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis
por: Lee, Michael H, et al.
Publicado: (2019)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
por: Tuhy, Tijana, et al.
Publicado: (2023)

Pulmonary arterial hypertension in Saudi patients with systemic sclerosis: Clinical and hemodynamic characteristics and mortality
por: Al Otair, Hadil AK., et al.
Publicado: (2019)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus
por: Cylwik, Bogdan, et al.
Publicado: (2021)

The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single–centre retrospective study
por: Pogorzelski, Ryszard, et al.
Publicado: (2014)

Loneliness among single and coupled individuals in response to the COVID-19 pandemic: A cross-country analysis
por: Adamczyk, Katarzyna, et al.
Publicado: (2023)

Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
por: Broen, JCA, et al.
Publicado: (2010)

Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans
por: Blanco, Isabel, et al.
Publicado: (2014)

Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2018)

Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody
por: Ishii, Yusho, et al.
Publicado: (2020)

Pulmonary Arterial Hypertension In Systemic Sclerosis: Challenges In Diagnosis, Screening And Treatment
por: Saygin, Didem, et al.
Publicado: (2019)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_al1lj7kmmhkduk9b6fqlf0jcqu